The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia.

Levine, Ross L; Loriaux, Marc; Huntly, Brian J P; Loh, Mignon L; Beran, Miroslav; Stoffregen, Eric; Berger, Roland; Clark, Jennifer J; Willis, Stephanie G; Nguyen, Kim T; Flores, Nikki J; Estey, Elihu; Gattermann, Norbert; Armstrong, Scott; Look, A Thomas; Griffin, James D; Bernard, Olivier A; Heinrich, Michael C; Gilliland, D Gary; Druker, Brian; Deininger, Michael W N

Levine, Ross L; Loriaux, Marc; Huntly, Brian J P; Loh, Mignon L; Beran, Miroslav; Stoffregen, Eric; Berger, Roland; Clark, Jennifer J; Willis, Stephanie G; Nguyen, Kim T; Flores, Nikki J; Estey, Elihu; Gattermann, Norbert; Armstrong, Scott; Look, A Thomas; Griffin, James D; Bernard, Olivier A; Heinrich, Michael C; Gilliland, D Gary; Druker, Brian; Deininger, Michael W N.

Affiliation

Levine RL; Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Blood ; 106(10): 3377-9, 2005 Nov 15.

Article in En | MEDLINE | ID: mdl-16081687

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protein-Tyrosine Kinases / Leukemia, Lymphoid / Leukemia, Myeloid / Proto-Oncogene Proteins / Point Mutation / Alleles Type of study: Observational_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2005 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google